Pharmacological modulation of ferroptosis, via iron chelators, GPX4 activation, and lipid peroxidation blockade, hold promise as adjuncts to current immunomodulatory approaches
Meanwhile, you can barely drag yourself out of bed, your libido is non-existent, and you're wondering if this is just what getting older feels like
ResMed CEO: Big Pharma is squarely focused on GLP-1 medications right now Image courtesy of ResMed ResMed CEO Mick Farrells stance on the issue is that the latest advances in both Big Tech and Big Pharma can potentially bring incredible numbers of new patients into the healthcare system where ResMed is uniquely positioned to provide ongoing care at home. Patients are voting with their wallets and respiratory therapists and physicians are voting with their recommendations and their prescriptions. During the companys first-quarter earnings call, Farrell said the company is laser-focused on growing the market to help people get on the therapy they need and on a pathway to better sleep, better health, and better long-term care
From a lightweight milky serum featuring NAD+ support to a crystal capsule cream designed for luminous hydration, these two formulas bring a fresh new way to care for dull, tired-looking skin
